All Stories

  1. Treatment of schizophrenia with catatonic symptoms

    Article • Schizophrenia Research, November 2022, Elsevier

    Dr. Stanley N. Caroff

  2. A new and more hopeful era in the diagnosis and treatment of tardive dyskinesia.

    Article • CNS Spectrums, October 2022, Cambridge University Press

    Dr. Stanley N. Caroff

  3. Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database

    Article • BMC Anesthesiology, September 2022, Springer Science + Business Media

    Dr. Stanley N. Caroff

  4. Catatonia during pregnancy and the postpartum period

    Article • Schizophrenia Research, September 2022, Elsevier

    Dr. Stanley N. Caroff

  5. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms

    Article • Cochrane Database of Systematic Reviews, July 2022, Wiley

    Dr. Stanley N. Caroff

  6. An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia

    Article • Clinical Psychopharmacology and Neuroscience, February 2022, Korean College of Neuropsychopharmacology (KAMJE)

    Dr. Stanley N. Caroff

  7. Commentary on the Continued Investigational Status of DBS for Psychiatric Indications

    Article • Stereotactic and Functional Neurosurgery, February 2022, Karger Publishers

    Dr. Stanley N. Caroff

  8. Historical depictions of the fencing posture illustrate the importance of catalepsy in diagnosis

    Article • Journal of Neuropsychiatry, February 2022, American Psychiatric Association

    Dr. Stanley N. Caroff

  9. Defining utility values for patients with tardive dyskinesia

    Article • Current Medical Research and Opinion, January 2022, Taylor & Francis

    Dr. Stanley N. Caroff

  10. Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents

    Article • Tremor and Other Hyperkinetic Movements, January 2022, Ubiquity Press, Ltd.

    Dr. Stanley N. Caroff

  11. Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study

    Article • Journal of the American Psychiatric Nurses Association, June 2021, SAGE Publications

    Dr. Stanley N. Caroff

  12. Effect of Varenicline on Tardive Dyskinesia: A Pilot Study

    Article • Clinical Psychopharmacology and Neuroscience, May 2021, Korean College of Neuropsychopharmacology (KAMJE)

    Dr. Stanley N. Caroff

  13. The Return of Psychedelics: Still Time to Prevent Tragedy

    Article • Psychiatric News, April 2021, American Psychiatric Association

    Dr. Stanley N. Caroff

  14. Drug-induced Hyperthermic Syndromes in Psychiatry

    Article • Clinical Psychopharmacology and Neuroscience, February 2021, Korean College of Neuropsychopharmacology (KAMJE)

    Dr. Stanley N. Caroff

  15. Recent Advances in the Pharmacology of Tardive Dyskinesia

    Article • Clinical Psychopharmacology and Neuroscience, November 2020, Korean College of Neuropsychopharmacology (KAMJE)

    Dr. Stanley N. Caroff

  16. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice

    Article • CNS Spectrums, November 2020, Cambridge University Press

    Dr. Stanley N. Caroff

  17. Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool

    Article • Parkinsonism & Related Disorders, August 2020, Elsevier

    Dr. Stanley N. Caroff

  18. Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia

    Article • BMC Psychiatry, July 2020, Springer Science + Business Media

    Dr. Stanley N. Caroff

  19. Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia

    Article • Journal of Clinical Psychopharmacology, July 2020, Wolters Kluwer Health

    Dr. Stanley N. Caroff

  20. Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors

    Article • Clinical Psychopharmacology and Neuroscience, May 2020, Korean College of Neuropsychopharmacology (KAMJE)

    Dr. Stanley N. Caroff

  21. RE-KINECT

    Article • Journal of Clinical Psychopharmacology, April 2020, Wolters Kluwer Health

    Dr. Stanley N. Caroff

  22. A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia

    Article • The Journal of Clinical Psychiatry, January 2020, Physicians Postgraduate Press, Inc

    Dr. Stanley N. Caroff

  23. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders

    Article • Journal of Clinical Psychopharmacology, December 2019, Wolters Kluwer Health

    Dr. Stanley N. Caroff

  24. Clinical clues to recognizing encephalitis presenting with behavioral symptoms.

    Article • Journal of Neuropsychiatry, October 2019, American Psychiatric Association

    Dr. Stanley N. Caroff

  25. Recent developments in drug-induced movement disorders: a mixed picture

    Article • The Lancet Neurology, September 2019, Elsevier

    Dr. Stanley N. Caroff

  26. Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial

    Article • Schizophrenia Research, June 2019, Elsevier

    Dr. Stanley N. Caroff

  27. Psychedelic Medicine: Much More Study Needed

    Article • Psychiatric News, May 2019, American Psychiatric Association

    Dr. Stanley N. Caroff

  28. Providing effective treatment of tardive dyskinesia

    Article • April 2019, Dove Medical Press

    Dr. Stanley N. Caroff

  29. Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia

    Article • BMC Psychiatry, September 2018, Springer Science + Business Media

    Dr. Stanley N. Caroff

  30. Revisiting the Abnormal Involuntary Movement Scale

    Article • The Journal of Clinical Psychiatry, June 2018, Physicians Postgraduate Press, Inc

    Dr. Stanley N. Caroff

  31. Historical perspectives on tardive dyskinesia

    Article • Journal of the Neurological Sciences, June 2018, Elsevier

    Dr. Stanley N. Caroff

  32. Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review

    Article • Journal of Comparative Effectiveness Research, February 2018, Future Medicine

    Dr. Stanley N. Caroff

  33. Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness

    Article • Community Mental Health Journal, December 2017, Springer Science + Business Media

    Dr. Stanley N. Caroff

  34. Pharmacological treatment of tardive dyskinesia: recent developments

    Article • Expert Review of Neurotherapeutics, July 2017, Taylor & Francis

    Dr. Stanley N. Caroff

  35. Parkinsonism-hyperthermia syndrome and deep brain stimulation

    Article • Canadian Journal of Anesthesia/Journal canadien d anesthésie, February 2017, Springer Science + Business Media

    Dr. Stanley N. Caroff

  36. A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome

    Article • Journal of Clinical Psychopharmacology, February 2017, Wolters Kluwer Health

    Dr. Stanley N. Caroff

  37. Anti–N-Methyl-D-Aspartate Receptor Encephalitis and Risk of Neuroleptic Malignant Syndrome

    Article • Pediatric Neurology, January 2017, Elsevier

    Dr. Stanley N. Caroff

  38. Drug-Induced Extrapyramidal Syndromes

    Article • Psychiatric Clinics of North America, September 2016, Elsevier

    Dr. Stanley N. Caroff

  39. Recurrent Idiopathic Catatonia: Implications beyond the Diagnostic and Statistical Manual of Mental Disorders 5th Edition

    Article • Clinical Psychopharmacology and Neuroscience, August 2015, Korean College of Neuropsychopharmacology (KAMJE)

    Dr. Stanley N. Caroff

  40. Neuroleptic malignant syndrome and the catatonic dilemma

    Article • Psychopharmacology, January 2015, Springer Science + Business Media

    Dr. Stanley N. Caroff

  41. Risk of neuroleptic malignant syndrome in patients with NMDAR encephalitis

    Article • Neurological Sciences, December 2014, Springer Science + Business Media

    Dr. Stanley N. Caroff

  42. Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

    Article • The Journal of Clinical Psychiatry, May 2012, Physicians Postgraduate Press, Inc

    Dr. Stanley N. Caroff

  43. Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial

    Article • Neurologic Clinics, February 2011, Elsevier

    Dr. Stanley N. Caroff

  44. A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2011, Elsevier

    Dr. Stanley N. Caroff

  45. Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

    Article • Journal of Ect, December 2010, Wolters Kluwer Health

    Professor Andrea Eugenio Cavanna, Dr. Stanley N. Caroff

  46. Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia

    Article • The Journal of Clinical Psychiatry, August 2010, Physicians Postgraduate Press, Inc

    Dr. Stanley N. Caroff

  47. Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects

    Article • Biological Psychiatry, February 2010, Elsevier

    Dr. Stanley N. Caroff

  48. Treatment of Catatonia With Methylphenidate in an Elderly Patient With Depression

    Article • Psychosomatics, January 2010, Elsevier

    Dr. Stanley N. Caroff

  49. Management of Schizophrenia with Substance Use Disorders

    Article • Psychiatric Clinics of North America, December 2009, Elsevier

    Dr. Stanley N. Caroff

  50. A candidate gene study of tardive dyskinesia in the CATIE schizophrenia trial

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2009, Wiley

    Dr. Stanley N. Caroff

  51. Neuroleptic Malignant Syndrome

    Article • American Journal of Psychiatry, June 2007, American Psychiatric Association

    Dr. Stanley N. Caroff

  52. Neuroleptic malignant syndrome

    Article • Adverse Drug Reaction Bulletin, August 2001, Wolters Kluwer Health

    Dr. Stanley N. Caroff

  53. Neuroleptic malignant syndrome

    Article • Medical Clinics of North America, January 1993, Elsevier

    Dr. Stanley N. Caroff